These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 1290290)

  • 1. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects].
    Steinbeck G
    Z Kardiol; 1992; 81 Suppl 4():139-43. PubMed ID: 1290290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pro-arrhythmic effects of anti-arrhythmia agents].
    Haverkamp W; Wichter T; Chen X; Hördt M; Willems S; Rotman B; Hindricks G; Kottkamp H; Borggrefe M; Breithardt G
    Z Kardiol; 1994; 83 Suppl 5():75-85. PubMed ID: 7846949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New aspects of the electrophysiologic effect of antiarrhythmic agents].
    Antoni H; Weirich J
    Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiac side effects of anti-arrhythmia agents].
    Seipel L
    Z Kardiol; 1988 Feb; 77(2):77-88. PubMed ID: 3284219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
    Gülker H; Thale J
    Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dangerous arrhythmias].
    Gertsch M; Fuhrer J
    Schweiz Med Wochenschr; 1993 May; 123(17):833-43. PubMed ID: 8497770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ventricular pro-arrhythmic effects of anti-arrhythmia drugs].
    Jaillon P; Simon T
    Therapie; 1992; 47(3):187-92. PubMed ID: 1295119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ion channels and arrhythmias].
    Borchard U; Hafner D
    Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B; Koller B; Rudolph W
    Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proarrhythmic (torsadogenic) effects of QT-prolonging non-antiarrhythmic drugs].
    Fazekas T; Liszkai G
    Orv Hetil; 2005 Mar; 146(10):451-60. PubMed ID: 15835343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New aspects of the molecular effect of anti-arrhythmia agents].
    Honerjäger P
    Herz; 1990 Apr; 15(2):70-8. PubMed ID: 2160907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problems with anti-arrhythmia therapy in atrial fibrillation].
    Breithardt G; Kottkamp H; Haverkamp W; Hindricks G; Fetsch T; Borggrefe M
    Z Kardiol; 1994; 83 Suppl 5():63-9. PubMed ID: 7846947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis].
    Milberg P; Pott C; Eckardt L; Breithardt G
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S285-9. PubMed ID: 19085808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of atrial fibrillation with class III anti-arrhythmia agents].
    Follath F; Candinas R; Frielingsdorf J
    Herz; 1993 Feb; 18(1):20-6. PubMed ID: 8454249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beat-to-beat variability of repolarization: a new parameter to determine arrhythmic risk of an individual or identify proarrhythmic drugs.
    Oosterhoff P; Oros A; Vos MA
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():73-8. PubMed ID: 17584687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arrhythmogenic effects of anti-arrhythmia agents].
    Pfeiffer D; Rostock KJ; Rathgen K; Schirdewan A; Kleiner HJ
    Z Gesamte Inn Med; 1987 Jul; 42(14):390-4. PubMed ID: 3673134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Unwanted cardiovascular effects of anti-arrhythmia agents].
    Libersa C; Caron J; Nisse C; Lacroix D; Fautrez V; Rouet R
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():41-7. PubMed ID: 1726996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.